These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 9010610

  • 1. Ibuprofen and diclofenac sodium in the treatment of osteoarthritis: a comparative trial of two once-daily sustained-release NSAID formulations.
    Baumgartner H, Schwarz HA, Blum W, Bruhin A, Gallachi G, Goldinger G, Saxer M, Trost H.
    Curr Med Res Opin; 1996; 13(8):435-44. PubMed ID: 9010610
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatism.
    Martens M.
    Clin Rheumatol; 1997 Jan; 16(1):25-31. PubMed ID: 9132322
    [Abstract] [Full Text] [Related]

  • 3. A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms.
    Grebe W, Ionescu E, Gold MS, Liu JM, Frank WO.
    Clin Ther; 2003 Feb; 25(2):444-58. PubMed ID: 12749506
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
    Hale M, Tudor IC, Khanna S, Thipphawong J.
    Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy and tolerability of two sustained-release formulations of diclofenac: results of a double-blind, randomised study in patients with osteoarthritis and a reappraisal of diclofenac's use in this patient population.
    Wagenitz A, Mueller EA, Frentzel A, Cambon N.
    Curr Med Res Opin; 2007 Aug; 23(8):1957-66. PubMed ID: 17631698
    [Abstract] [Full Text] [Related]

  • 6. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis.
    Cheng TT, Lai HM, Chiu CK, Chem YC.
    Clin Ther; 2004 Mar; 26(3):399-406. PubMed ID: 15110132
    [Abstract] [Full Text] [Related]

  • 7. Relief of acute low back pain with diclofenac-K 12.5 mg tablets: a flexible dose, ibuprofen 200 mg and placebo-controlled clinical trial.
    Dreiser RL, Marty M, Ionescu E, Gold M, Liu JH.
    Int J Clin Pharmacol Ther; 2003 Sep; 41(9):375-85. PubMed ID: 14518597
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacy and tolerability of two diclofenac formulations in the treatment of painful osteoarthritis.
    Bakshi R.
    Br J Clin Pract; 1996 Sep; 50(6):294-7. PubMed ID: 8983316
    [Abstract] [Full Text] [Related]

  • 9. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
    Hawkey C, Kahan A, Steinbrück K, Alegre C, Baumelou E, Bégaud B, Dequeker J, Isomäki H, Littlejohn G, Mau J, Papazoglou S.
    Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.
    Pareek A, Chandanwale AS, Oak J, Jain UK, Kapoor S.
    Curr Med Res Opin; 2006 May; 22(5):977-88. PubMed ID: 16709320
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR, Feist E, Wolfram G, Davignon I, Smith MD, Brown MT, West CR.
    Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
    Lister BJ, Poland M, DeLapp RE.
    Am J Med; 1993 Aug 09; 95(2A):2S-9S. PubMed ID: 8356999
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of diclofenac in osteoarthritis: Results of a network meta-analysis of unpublished legacy studies.
    Guyot P, Pandhi S, Nixon RM, Iqbal A, Chaves RL, Andrew Moore R.
    Scand J Pain; 2017 Jul 09; 16():74-88. PubMed ID: 28850416
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M, Berggren AC.
    Clin Ther; 2009 Mar 09; 31(3):503-13. PubMed ID: 19393841
    [Abstract] [Full Text] [Related]

  • 16. Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group.
    Saag K, van der Heijde D, Fisher C, Samara A, DeTora L, Bolognese J, Sperling R, Daniels B.
    Arch Fam Med; 2000 Mar 09; 9(10):1124-34. PubMed ID: 11115219
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.
    Zacher J, Feldman D, Gerli R, Scott D, Hou SM, Uebelhart D, Rodger IW, Ozturk ZE, etoricoxib OA study group.
    Curr Med Res Opin; 2003 Mar 09; 19(8):725-36. PubMed ID: 14687444
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Double-blind comparison of etodolac SR and diclofenac SR in the treatment of patients with degenerative joint disease of the knee.
    Khan FM, Williams PI.
    Curr Med Res Opin; 1992 Mar 09; 13(1):1-12. PubMed ID: 1468239
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group.
    Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, Helgetveit KB, Kress B, Daniels B, Bolognese J, Krupa D, Seidenberg B, Ehrich E.
    Arch Intern Med; 2000 Jun 26; 160(12):1781-7. PubMed ID: 10871971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.